Considering the greater annual changes in tau and the stronger association between the tau load and cognition compared to Aβ, tau PET imaging is perhaps more suitable as an indicator of disease progression, even in the advanced stage of AD. This evidence concerns the gene MAPT and Alzheimer disease.